MARKET

PBMWW

PBMWW

PSYENCE BIOMEDICAL LTD
NASDAQ
0.0235
+0.0045
+23.68%
Closed 15:27 02/11 EST
OPEN
0.0212
PREV CLOSE
0.0190
HIGH
0.0235
LOW
0.0194
VOLUME
10.76K
TURNOVER
494
52 WEEK HIGH
0.0411
52 WEEK LOW
0.0100
MARKET CAP
--
P/E (TTM)
-0.0012
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-Psyence BioMed gains on dispute settlement with shareholder KAOS Capital
Reuters · 22h ago
Psyence Biomedical Settles Shareholder Litigation with KAOS Capital for $1.5 Million
Reuters · 22h ago
PSYENCE BIOMEDICAL LTD - SETTLEMENT TO BE FUNDED BY CASH ON HAND
Reuters · 22h ago
Weekly Report: what happened at PBMWW last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at PBMWW last week (0126-0130)?
Weekly Report · 02/02 09:14
Psyence Biomedical Announces 1-for-6.25 Reverse Stock Split Effective February 2
Reuters · 01/28 23:30
PSYENCE BIOMED ANNOUNCES EFFECTIVE DATE FOR 1-FOR-6.25 REVERSE STOCK SPLIT
Reuters · 01/28 23:30
Weekly Report: what happened at PBMWW last week (0119-0123)?
Weekly Report · 01/26 09:14
More
About PBMWW
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Webull offers Psyence Biomedical Ltd stock information, including NASDAQ: PBMWW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBMWW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBMWW stock methods without spending real money on the virtual paper trading platform.